glp-1 and blood clots April 2025 PEP Talk: Weight, Clots, Drugs GLP-1 Agonists in Cardiovascular Diseases:

If cost is your primary barrier, compounded programs can offer meaningful savings but require careful vetting

Effect of central administration of GLP-1R analogs on food intake The acute anorectic effect of centrally administered GLP-1 was described simultaneously 1996 by Steve Bloom's group [668] and by Mads Tang-Christensen et al

Increased insulin secretion during a fasting state was also observed for other long-acting GLP-1 RAs such as dulaglutide (Trulicity) [110] and albiglutide (Tanzeum) [111]

Other GLP-1 drugs commonly named in the broader lawsuits include: GLP-1 drugs were originally developed to treat diabetes by improving blood sugar control, but their use has expanded rapidly alongside growing interest in weight loss medications

Automated Alerts: Patients can sign-up to receive automated email alerts, delivered when a GLP-1 drug is reported in supply in their area or when the status of a GLP-1 drug changes on the FDA's Drug Shortage List

*Promotion: Get $100 off your first month of Weight Loss injections as a new client